Lupus Anticoagulant-hypoprothrombinemia Syndrome as an Initial Manifestation of Systemic Lupus Erythematosus: A Case Report / 임상소아혈액종양
Clinical Pediatric Hematology-Oncology
;
: 145-148, 2014.
Article
in Korean
| WPRIM
| ID: wpr-788517
ABSTRACT
The lupus anticoagulant-hypoprothrombinemia syndrome, characterized by presence of lupus anticoagulant with acquired factor II deficiency, is a rare disease entity often presented with acute bleeding episodes. A 15-year-old girl was hospitalized with 3 month history of menorrhagia and easy bruising. Prothrombin time (31.3 sec, normal value 10-13 sec) and activated partial thromboplastin time (72.5 sec, normal value 27.5-34.7 sec) were markedly prolonged and partially corrected after mixing with normal plasma. Decreased Factor II activity (4%, normal range 79-131%) or prolonged dilute Russell's viper venom time (89.8 sec, normal value 25.4-34.3 sec), was consistent with lupus anticoagulant-hypoprothrombinemia syndrome. Antinuclear antibody, anti-double strand-DNA antibodies and anticardiolipin antibodies were also positive. Bleeding diathesis tends to wax and wane while 5 years of treatment with steroid combined with immunosuppressants, however, there was no more active bleeding episodes. Several years after diagnosis, myocarditis, pericarditis, seizure was occurred, fulfilled the diagnostic criteria of systemic lupus erythematosus.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Partial Thromboplastin Time
/
Pericarditis
/
Plasma
/
Prothrombin Time
/
Reference Values
/
Seizures
/
Prothrombin
/
Antibodies, Antinuclear
/
Lupus Coagulation Inhibitor
/
Antibodies, Anticardiolipin
Type of study:
Diagnostic study
Limits:
Adolescent
/
Female
/
Humans
Language:
Korean
Journal:
Clinical Pediatric Hematology-Oncology
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS